FridayJun 30, 2023 2:40 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Published Peer-Reviewed Article on DehydraTECH(TM)-CBD, Bringing Publication Total to Eight

Lexaria’s latest peer-reviewed publications were published in June 2023 in the International Journal of Molecular Sciences, Advances in Therapy, and Biomedicine & Pharmacotherapy Lexaria’s eight peer-reviewed publications support the company’s pursuit of launching an FDA-registered IND program to formally investigate DehydraTECH(TM)-CBD for hypertension The global cardiovascular drug market was worth $146.5 billion and is expected to reach $173.5 billion in 2026 – making patent protection crucial in commercial markets To date, Lexaria has a robust intellectual property portfolio with 34 patents granted and many more pending worldwide Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced…

Continue Reading

FridayJun 30, 2023 11:30 am

Freight Technologies Inc. (NASDAQ: FRGT) Announces a Significant Development for Platform Users –Samsara Integration

FRGT just announced its new integration with Samsara, the pioneer of Connected Operations(TM) Cloud The move is seen as a “gamechanger,” with Fr8App customers now able to view and leverage insights from Samsara’s vehicle telematics solution Fr8App’s management is confident that by connecting with industry leaders like Samsara, the company will continue to pave the way for streamlined logistics processes and improved visibility for customers In addition, the move solidifies Fr8App’s position as the most connected and integrable platform for cross-border shipping in North America Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a tech company on a mission to revolutionize cross-border shipping…

Continue Reading

WednesdayJun 28, 2023 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Grows Robust Intellectual Property Portfolio to 34 Worldwide Patents with Receipt of 4 New Granted in Canada, US

Lexaria Bioscience recently received four new patents granted in Canada and the United States In the U.S., the company received two new hypertension-related patents expected to be of particular importance as the company pursues FDA approval for a Phase 1b study evaluating DehydraTECH(TM)-processed CBD So far, the company has a robust intellectual property portfolio comprising 34 patents granted worldwide The strong portfolio gives the company the necessary impetus and peace of mind to pursue multiple large markets, starting with the multi-billion dollar cardiovascular drugs market The company has conducted five human clinical studies that have provided insights into the potential…

Continue Reading

TuesdayJun 27, 2023 9:45 am

Cepton, Inc. (NASDAQ: CPTN) Advances Lidar Solutions Enabling Automatic Emergency Braking, NHTSA Pushes for New Rules

Automatic Emergency Braking (“AEB”) uses sensors to monitor and detect obstacles and apply the brakes to either prevent the collision or reduce impact severity The Insurance Institute for Highway Safety (“IIHS”) conducted a study revealing that AEB with pedestrian detection was associated with a 29%-30% reduction in pedestrian injury crash risk The U.S. Department of Transportation’s National Highway Traffic Safety Administration (“NHTSA”) recently announced a Notice of Proposed Rulemaking requiring AEB on all new passenger cars and light trucks Cepton’s Vista(R)-X90 Plus is billed as the “world’s smallest” lidar with extensive integration capabilities allowing manufacturers to seamlessly embed the system…

Continue Reading

MondayJun 26, 2023 11:15 am

D-Wave Quantum Inc. (NYSE: QBTS) Supports Governments’ Investment in Near-Term Quantum Applications

D-Wave’s technology is geared toward optimization problems commonly faced by the public sector Governments worldwide are engaging with quantum computing to solve public sector problems and build domestic supply chains and workforces D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services focused on delivering value via practical quantum applications, is helping fuel the adoption of near-term quantum computing solutions against a backdrop of increased government assessment, investment and legislation. As more governments start to consider quantum applications and the use of quantum technologies to solve public sector challenges, D-Wave offers solutions oriented towards addressing optimization problems…

Continue Reading

FridayJun 23, 2023 11:30 am

Freight Technologies Inc. (NASDAQ: FRGT) Enters New Stage With Dedicated AI Development Division

Texas-headquartered Freight Technologies (aka Fr8Tech) is a technology innovation company dedicated to sustaining over-the-road (“OTR”) commercial shipments within the USMCA (formerly NAFTA) North American trading area The company’s core Fr8App product is a cloud-based freight matching platform that uses artificial intelligence and machine learning to help shippers and carriers match up their loads, capacity, and destinations Fr8Tech is growing its artificial intelligence development, appointing Dr. Umberto León-Domínguez to oversee the creation of a dedicated AI department Fr8App was recently cited by Google Maps Platform’s blog as an innovative use of advanced markers from the platform to interactively help end users…

Continue Reading

FridayJun 23, 2023 9:45 am

Genprex Inc. (NASDAQ: GNPX) CMO Discusses Recent Company Announcements in Bell2Bell Podcast Episode

Genprex Chief Medical Officer, Dr. Mark Berger, was featured in a recent Bell2Bell Podcast episode, where he discussed the company’s recent announcements In May, the company received Safety Review Committee (“SRC”) approval to advance to the Phase 2 expansion portion of its Acclaim-1 clinical trial of its lead candidate, REQORSA(R) Immunogene Therapy The Phase 1 dose escalation portion of the study showed that REQORSA(R) was generally well tolerated, and there were no dose-limiting toxicities; Genprex also reported encouraging evidence of efficacy in this portion In April, Genprex announced that its research collaborators presented in vivo mouse data showing that Genprex’s…

Continue Reading

FridayJun 23, 2023 9:00 am

Cepton, Inc. (NASDAQ: CPTN) Expands Collaboration with NVIDIA, Releases New Financial Update Revealing Progress on Volume Production

Cepton integrated Vista-X120 Plus lidar into NVIDIA Omniverse platform to enable real-time simulation and 3D visualization to streamline lidar deployment processes and reduce cost for automakers Vista-X120 Plus features a software-definable ROI, allows users to dynamically adjust and optimize lidar performance and power consumption based on specific scenarios or areas that require additional attention Cepton released a financial update revealing it was on track to receive final production validation for salable vehicles and continue shipment of pre-production lidar units for multiple vehicle models Additional update highlights included completed implementation of embedded lidar software, and execution of RFQ and RFI responses…

Continue Reading

ThursdayJun 22, 2023 11:15 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Additional Findings in Diabetes Animal Study and Two Other R&D Programs

Diabetes – Blood glucose levels reduced by 19.9% with patented DehydraTECH(TM) processed CBD Epilepsy – Lower dosages of DehydraTECH-CBD were needed to achieve the same results of Epidiolex(R) in the company’s animal epilepsy study Dementia – Lexaria determined that a longer testing duration is needed for DehydraTECH-CBD in cognition studies Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, including the company’s patented DehydraTECH(TM) technology, recently reported additional findings from its diabetes animal study DIAB-A22-1, as well as updates on two other applied R&D programs for dementia (DEM-A22-1) and epilepsy (EPIL-A21-1). In March, Lexaria announced that it had…

Continue Reading

WednesdayJun 21, 2023 9:00 am

Cepton, Inc. (NASDAQ: CPTN) Reveals Use of Lidar Technology in Texas & Utah Traffic Initiative; Announces Hire of Luis Gonçalves as Director of Customer Programs

Cepton recently revealed that its lidar technology has been deployed to bolster traffic infrastructure in Texas and Utah The announcement marks a continued trend, which has seen Cepton’s lidar solutions increasingly used to facilitate traffic management and smart city infrastructure – most recently announcing their multi-million contract with a leading U.S. tolling system operator With the company seeing growing business opportunities, as well as being fully committed to executing its flagship lidar series production program by a Top 3 automotive OEM, Cepton has looked to take the next step in its journey with the addition of Luis Gonçalves to its…

Continue Reading

Contact us: (310) 299-1717